Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$108,648
-$18,048 QoQ
Shares Held
4,512
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#2,531
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cranbrook Wealth Management, LLC holds $5,931,680 across 8 Drug Manufacturers - General names. PFE ranks #6 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
14,566 | $3,665,388 | |
| 2 | JNJ |
Johnson & Johnson
|
4,440 | $1,127,626 | |
| 3 | MRK |
Merck & Co., Inc.
|
4,154 | $533,789 | |
| 4 | LLY |
ELI LILLY & Co
|
287 | $344,236 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
2,136 | $123,076 | |
| 6 | PFE |
Pfizer Inc
This page
|
4,512 | $108,648 | |
| 7 | GSK |
GSK plc
|
508 | $26,629 | |
| 8 | OGN |
Organon & Co.
|
169 | $2,288 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,648 | 4,512 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $126,696 | 4,512 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $112,348 | 4,512 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $114,965 | 4,512 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $109,370 | 4,512 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $114,334 | 4,512 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $122,940 | 4,634 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $134,107 | 4,634 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $129,407 | 4,625 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $128,343 | 4,625 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $133,153 | 4,625 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $144,787 | 4,365 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $160,108 | 4,365 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $178,092 | 4,365 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $230,067 | 4,490 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $198,670 | 4,540 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $224,347 | 4,279 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $221,523 | 4,279 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $266,551 | 4,514 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $201,028 | 4,674 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $172,852 | 4,414 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $159,919 | 4,414 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $162,479 | 4,414 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $161,993 | 4,414 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $144,337 | 4,414 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $144,072 | 4,414 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||